The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3alpha,16alpha,17beta)-3-[(trans-2,5-Dimethyl-4-{[2-(trifluoromethyl)phenyl]sulfonyl}piperazin-1-yl)methyl]-androstane-3,16,17-triol ID: ALA4518459
PubChem CID: 155541533
Max Phase: Preclinical
Molecular Formula: C33H49F3N2O5S
Molecular Weight: 642.83
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1CN(S(=O)(=O)c2ccccc2C(F)(F)F)C(C)CN1C[C@@]1(O)CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]32)C1
Standard InChI: InChI=1S/C33H49F3N2O5S/c1-20-18-38(44(42,43)28-8-6-5-7-25(28)33(34,35)36)21(2)17-37(20)19-32(41)14-13-30(3)22(16-32)9-10-23-24(30)11-12-31(4)26(23)15-27(39)29(31)40/h5-8,20-24,26-27,29,39-41H,9-19H2,1-4H3/t20?,21?,22-,23+,24-,26-,27+,29-,30-,31-,32+/m0/s1
Standard InChI Key: HTTLGEZVHGKHLL-LTVVLKPRSA-N
Molfile:
RDKit 2D
48 53 0 0 0 0 0 0 0 0999 V2000
17.9433 -6.7553 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2302 -6.3425 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.2292 -7.1664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3110 -4.2200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7280 -3.5069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9020 -3.5023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7280 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4406 -3.9156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4406 -2.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1532 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1497 -3.5069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8590 -3.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5764 -3.5130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8660 -2.2692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5760 -2.6899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5929 -1.0424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8714 -1.4462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3028 -1.4630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2939 -2.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0731 -2.5478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5637 -1.8878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0876 -1.2175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2975 -0.6338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2892 -3.1108 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
24.3513 -0.4351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5678 -1.8640 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
21.8588 -3.0941 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
21.1458 -1.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1416 -4.3284 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
18.4852 -4.2151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6623 -4.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2457 -4.9127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6510 -5.6325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4776 -5.6391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8989 -4.9259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4059 -6.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0037 -5.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1788 -5.6075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7585 -6.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1690 -7.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9925 -7.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2572 -3.4848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8840 -6.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4004 -7.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7728 -8.4175 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.0898 -8.5702 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.2514 -7.9069 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.3893 -1.8968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 1 0
5 6 1 1
7 5 1 0
7 9 1 0
5 8 1 0
8 11 1 0
10 9 1 0
10 11 1 0
10 14 1 0
11 12 1 0
12 13 1 0
13 15 1 0
14 15 1 0
14 17 1 0
15 19 1 0
18 16 1 0
16 17 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
18 23 1 1
19 24 1 6
22 25 1 1
15 26 1 1
14 27 1 6
10 28 1 1
11 29 1 6
6 30 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
33 2 1 0
2 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 36 1 0
31 42 1 0
34 43 1 0
44 45 1 0
44 46 1 0
44 47 1 0
41 44 1 0
21 48 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 642.83Molecular Weight (Monoisotopic): 642.3314AlogP: 4.89#Rotatable Bonds: 4Polar Surface Area: 101.31Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.56CX Basic pKa: 7.37CX LogP: 4.47CX LogD: 4.18Aromatic Rings: 1Heavy Atoms: 44QED Weighted: 0.43Np Likeness Score: 0.71
References 1. Cortés-Benítez F, Roy J, Perreault M, Maltais R, Poirier D.. (2019) A- and D-Ring Structural Modifications of an Androsterone Derivative Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure-Activity Relationships., 62 (15): [PMID:31268309 ] [10.1021/acs.jmedchem.9b00624 ]